Flecainide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C17H20F6N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) K94FTS1806, chemically known as n-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide but more generally known as flecainide, which bears US NIH Compound Identifier 3356. European Medicines Agency schedules Flecainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07637MIG. The term FLECAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules flecainide in its Anatomical Therapeutic Chemical (ATC) Classification. FLECAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule flecainide under HS 29333999 and SITC 51574. As of Q4 2014, FLECAINIDE remains US FDA's Preferred Term for this commodity. Flecainide bears US NLM identifiers UMLS ID C0016229 and NCI Concept Code C62029. SMILES: FC(F)(F)COC1C(C(=O)NCC2NCCCC2)CC(OCC(F)(F)F)CC1.